Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 716,000 | 764,200 | 821,200 | 812,600 | 811,500 |
| Cost of Goods | 264,900 | 289,100 | 313,900 | 304,700 | 306,900 |
| Gross Profit | 451,100 | 475,100 | 507,300 | 507,900 | 504,600 |
| Operating Expenses | 429,500 | 416,200 | 408,700 | 413,600 | 418,300 |
| Operating Income | 22,500 | 59,000 | 99,500 | 95,000 | 87,200 |
| Interest Expense | 31,700 | 31,100 | 30,700 | 31,400 | 31,900 |
| Other Income | 33,200 | 13,700 | 10,300 | 20,100 | 16,200 |
| Pre-tax Income | 24,000 | 41,600 | 79,100 | 83,700 | 71,500 |
| Income Tax | 12,600 | 18,000 | 30,700 | 29,800 | 29,200 |
| Net Income Continuous | 11,400 | 23,600 | 48,400 | 53,900 | 42,300 |
| Net Income | $11,400 | $23,600 | $48,400 | $53,900 | $42,300 |
| EPS Basic Total Ops | 0.07 | 0.15 | 0.31 | 0.35 | 0.27 |
| EPS Basic Continuous Ops | 0.07 | 0.15 | 0.31 | 0.35 | 0.27 |
| EPS Diluted Total Ops | 0.07 | 0.15 | 0.31 | 0.35 | 0.27 |
| EPS Diluted Continuous Ops | 0.07 | 0.15 | 0.31 | 0.34 | 0.27 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.16 | 0.32 | 0.33 | 0.29 |
| EBITDA(a) | $86,300 | $123,100 | $161,600 | $155,800 | $146,900 |